Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Substance Abuse, Intravenous/complications"'
Autor:
Fatemeh Tavakoli, Najmeh Parhizgari, Mostafa Shokoohi, Mehrdad Khezri, Ali Akbar Haghdoost, Iman Ghasemzadeh, Ivana Bozicevic, Armita Shahesmaeili, Naser Nasiri, Ahmad Danesh, Mohammad Karamouzian, Hamid Sharifi
Publikováno v:
BMC Infectious Diseases. 22
Background Incarcerated people are at a disproportionate risk of contracting HIV. We estimated the prevalence and correlates of HIV testing among incarcerated people with a history of HIV-related high-risk behaviours in Iran. Methods Data for this an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8f63afea07f3b1e6470832d08f1d3d0
https://doi.org/10.1186/s12879-022-07897-z
https://doi.org/10.1186/s12879-022-07897-z
Autor:
Rebekka Faber Thudium, Jenny Dahl Knudsen, Susanne Dam Nielsen, Sara Thønnings, Christoffer Sundqvist, Filip Jansåker
Publikováno v:
BMC Infectious Diseases
Thønnings, S, Jansåker, F, Sundqvist, C, Thudium, R F, Nielsen, S D & Knudsen, J D 2020, ' Prevalence and recurrence of bacteraemia in hospitalised people who inject drugs : a single Centre retrospective cohort study in Denmark ', BMC Infectious Diseases, vol. 20, 634 . https://doi.org/10.1186/s12879-020-05357-0
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-7 (2020)
Thønnings, S, Jansåker, F, Sundqvist, C, Thudium, R F, Nielsen, S D & Knudsen, J D 2020, ' Prevalence and recurrence of bacteraemia in hospitalised people who inject drugs : a single Centre retrospective cohort study in Denmark ', BMC Infectious Diseases, vol. 20, 634 . https://doi.org/10.1186/s12879-020-05357-0
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-7 (2020)
Background People who inject drugs (PWID) have increased risk of acquiring blood-transmitted chronic viral infections such as Hepatitis B (HBV), Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV) as well as increased risk of acquiring bacterial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90cea8b4da3cdeb7fdc87eb835e9740c
http://europepmc.org/articles/PMC7448349
http://europepmc.org/articles/PMC7448349
Autor:
Håvard Midgard, Kjell Arne Johansson, Christian Ohldieck, Lars Thore Fadnes, Rafael Alexander Mo Leiva, Fatemeh Chalabianloo, Peter Vickerman, Olav Dalgard, Svetlana Skurtveit, Jørn Henrik Vold, Else-Marie Løberg, Christer Frode Aas, Ole Jørgen Scheie Lygren
Publikováno v:
BMC Infectious Diseases
Lim, A G 2019, ' Integrated treatment of hepatitis C virus infection among people who inject drugs : study protocol for a randomised controlled trial (INTRO-HCV) ', BMC Infectious Diseases, vol. 19, no. 1, pp. 943 . https://doi.org/10.1186/s12879-019-4598-7
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
19:943
Lim, A G 2019, ' Integrated treatment of hepatitis C virus infection among people who inject drugs : study protocol for a randomised controlled trial (INTRO-HCV) ', BMC Infectious Diseases, vol. 19, no. 1, pp. 943 . https://doi.org/10.1186/s12879-019-4598-7
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
19:943
Background A large proportion of people who inject drugs (PWID) living with hepatitis C virus (HCV) infection have not been treated. It is unknown whether inclusion of HCV diagnostics and treatment into integrated substance use disorder treatment and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1f306d442ea3e9249dc76b5005b9b93
https://pubmed.ncbi.nlm.nih.gov/31703669
https://pubmed.ncbi.nlm.nih.gov/31703669
Ruptured pseudo-aneurysm of a femoral artery in a drug abuser revealed by post-mortem CT angiography
Autor:
Katarzyna Michaud, F. Doenz, Patrice Mangin, Maria del Mar Lesta, Marc Augsburger, Silke Grabherr
Publikováno v:
International journal of legal medicine, vol. 127, no. 4, pp. 819-823
International Journal of Legal Medicine, Vol. 127, No 4 (2013) pp. 819-823
International Journal of Legal Medicine, Vol. 127, No 4 (2013) pp. 819-823
A 35-year-old drug addict was found dead in a public toilet with a ruptured groin, which was later diagnosed to be a leaking pseudo-aneurysm. Investigation at the scene revealed impressive external hemorrhage related to a groin wound. Post-mortem com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfde76ea8dba74e6a2974c538cf02a18
http://doc.rero.ch/record/321331/files/414_2012_Article_803.pdf
http://doc.rero.ch/record/321331/files/414_2012_Article_803.pdf
Autor:
Kelly Safreed-Harmon, Nina Weis, Olav Dalgard, Hannu Alho, Tove Frisch, Soo Aleman, Kristina L. Hetherington, Jeffrey V. Lazarus, Magnus Gottfredsson
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0190146 (2018)
Recercat. Dipósit de la Recerca de Catalunya
instname
Hep-Nordic Study Group 2018, ' Policy responses to hepatitis C in the Nordic countries : Gaps and discrepant reporting in the Hep-Nordic study ', PLoS ONE, vol. 13, no. 1, e0190146 . https://doi.org/10.1371/journal.pone.0190146
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE
Recercat. Dipósit de la Recerca de Catalunya
instname
Hep-Nordic Study Group 2018, ' Policy responses to hepatitis C in the Nordic countries : Gaps and discrepant reporting in the Hep-Nordic study ', PLoS ONE, vol. 13, no. 1, e0190146 . https://doi.org/10.1371/journal.pone.0190146
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE
Background and aims In the Nordic countries (Denmark, Finland, Iceland, Norway, Sweden), the prevalence of chronic hepatitis C virus (HCV) infection is relatively low in the general population, but is much higher among people who inject drugs (PWID).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d8e0ea6e192d723962155793a80b5da
http://europepmc.org/articles/PMC5790214?pdf=render
http://europepmc.org/articles/PMC5790214?pdf=render
Autor:
Mojca Matičič, John F. Dillon, David J. Goldberg, Bernd Schulte, Daniela K van Santen, Ruth Zimmermann, Viktor Mravčík, Sharon J. Hutchinson, Henrikki Brummer-Korvenkontio, Matthew Hickman, Hannah Fraser, Håvard Midgard, Maria Prins, Natasha K. Martin, Martin Kåberg, Peter Vickerman, Jens Reimer, Anne Øvrehus, Patrizia Carrieri, Olav Dalgard, Geert Robaeys, Amy Matser, Marie Jauffret-Roustide
Publikováno v:
Journal of Hepatology
Journal of Hepatology, 2018, 68 (3), pp.402-411. ⟨10.1016/j.jhep.2017.10.010⟩
Journal of hepatology, 68(3), 402-411. Elsevier
Fraser, H, Martin, N, Brummer-Korvenkontio, H, Carrieri, P, Dalgard, O, Dillon, J, Goldberg, D, Hutchinson, S, Jauffret-Roustide, M, Kaberg, M, Matser, A, Matičič, M, Midgard, H, Mravčík, V, Øvrehus, A, Prins, M, Reimer, J, Robaeys, G, Schulte, B, van Santen, D, Zimmermann, R, Vickerman, P & Hickman, M 2018, ' Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe ', Journal of Hepatology, vol. 68, no. 3, pp. 402-411 . https://doi.org/10.1016/j.jhep.2017.10.010
Journal of Hepatology, Elsevier, 2018, 68 (3), pp.402-411. ⟨10.1016/j.jhep.2017.10.010⟩
Fraser, H, Martin, N K, Brummer-Korvenkontio, H, Carrieri, P, Dalgard, O, Dillon, J, Goldberg, D, Hutchinson, S, Jauffret-Roustide, M, Kåberg, M, Matser, A A, Matičič, M, Midgard, H, Mravcik, V, Øvrehus, A, Prins, M, Reimer, J, Robaeys, G, Schulte, B, van Santen, D K, Zimmermann, R, Vickerman, P & Hickman, M 2018, ' Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe ', Journal of Hepatology, vol. 68, no. 3, pp. 402-411 . https://doi.org/10.1016/j.jhep.2017.10.010
Journal of Hepatology, 2018, 68 (3), pp.402-411. ⟨10.1016/j.jhep.2017.10.010⟩
Journal of hepatology, 68(3), 402-411. Elsevier
Fraser, H, Martin, N, Brummer-Korvenkontio, H, Carrieri, P, Dalgard, O, Dillon, J, Goldberg, D, Hutchinson, S, Jauffret-Roustide, M, Kaberg, M, Matser, A, Matičič, M, Midgard, H, Mravčík, V, Øvrehus, A, Prins, M, Reimer, J, Robaeys, G, Schulte, B, van Santen, D, Zimmermann, R, Vickerman, P & Hickman, M 2018, ' Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe ', Journal of Hepatology, vol. 68, no. 3, pp. 402-411 . https://doi.org/10.1016/j.jhep.2017.10.010
Journal of Hepatology, Elsevier, 2018, 68 (3), pp.402-411. ⟨10.1016/j.jhep.2017.10.010⟩
Fraser, H, Martin, N K, Brummer-Korvenkontio, H, Carrieri, P, Dalgard, O, Dillon, J, Goldberg, D, Hutchinson, S, Jauffret-Roustide, M, Kåberg, M, Matser, A A, Matičič, M, Midgard, H, Mravcik, V, Øvrehus, A, Prins, M, Reimer, J, Robaeys, G, Schulte, B, van Santen, D K, Zimmermann, R, Vickerman, P & Hickman, M 2018, ' Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe ', Journal of Hepatology, vol. 68, no. 3, pp. 402-411 . https://doi.org/10.1016/j.jhep.2017.10.010
Background & Aims: Prevention of hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is critical for eliminating HCV in Europe. We estimated the impact of current and scaled-up HCV treatment with and without scaling up opioid su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea756d10b6f89a0f5b8beaecc8739e57
https://hal-amu.archives-ouvertes.fr/hal-02146845
https://hal-amu.archives-ouvertes.fr/hal-02146845
Autor:
Helen R. Stagg, H Lucy Thomas, Andrew Skingsley, Zheng Yin, Anton Pozniak, Maeve K. Lalor, Alison Brown, Joanne R. Winter, Colette J. Smith, Peter Kirwan, Ibrahim Abubakar, Marc Lipman, Valerie Delpech
Publikováno v:
Winter, J R, Stagg, H R, Smith, C J, Brown, A E, Lalor, M K, Lipman, M, Pozniak, A, Skingsley, A, Kirwan, P, Yin, Z, Thomas, H L, Delpech, V & Abubakar, I 2017, ' Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV ', AIDS, vol. 31, no. 17, pp. 2403-2413 . https://doi.org/10.1097/QAD.0000000000001635
AIDS
AIDS
OBJECTIVES: Tuberculosis (TB) is common in people living with HIV, leading to worse clinical outcomes including increased mortality. We investigated risk factors for developing TB following HIV diagnosis.DESIGN: Adults aged at least 15 years first pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d12d5e71e5e442833f903730b1e93bb
https://hdl.handle.net/20.500.11820/b3692173-4a94-40b2-9471-90c4064bb3ec
https://hdl.handle.net/20.500.11820/b3692173-4a94-40b2-9471-90c4064bb3ec
Autor:
Bernard Hirschel, Heiner C. Bucher, Thomas Wagels, Markus Flepp, Amalio Telenti, Enos Bernasconi, Bruno Ledergerber, Claudine Zellweger
Publikováno v:
AIDS, Vol. 16, No 3 (2002) pp. 381-385
OBJECTIVES: Many patients have simplified their therapy by replacing protease inhibitors (PI) with efavirenz. In a large cohort study representative of clinical practice, we compared outcomes in patients who replaced PI with efavirenz (switchers), wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7319d5634ae8abd517e66a501c29eca9
https://doi.org/10.1097/00002030-200202150-00009
https://doi.org/10.1097/00002030-200202150-00009
Autor:
Steen Ladelund, Zitta Barrella Harboe, Mette Vang Larsen, Court Pedersen, Gitte Kronborg, Helle Bossen Konradsen, Niels Obel, Gitte Pedersen, Jan Gerstoft, Carsten Schade Larsen, Thomas Benfield
Publikováno v:
Harboe, Z B, Larsen, M V, Ladelund, S, Kronborg, G, Konradsen, H B, Gerstoft, J, Larsen, C S, Pedersen, C, Pedersen, G, Obel, N & Benfield, T 2014, ' Incidence and Risk Factors for Invasive Pneumococcal Disease in HIV-infected and non-HIV infected Individuals Before and After the Introduction of Combination Antiretroviral Therapy : Persisting High Risk among HIV-infected Injecting Drug Users ', Clinical Infectious Diseases, vol. 59, no. 8, pp. 1168-1176 . https://doi.org/10.1093/cid/ciu558
Harboe, Z B, Larsen, M, Ladelund, S, Kronborg, G, Konradsen, H B, Gerstoft, J, Larsen, C S, Pedersen, C, Pedersen, G, Obel, N & Benfield, T 2014, ' Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy : persistent high risk among HIV-infected injecting drug users ', Clinical Infectious Diseases, vol. 59, no. 8, pp. 1168-76 . https://doi.org/10.1093/cid/ciu558
Harboe, Z B, Larsen, M, Ladelund, S, Kronborg, G, Konradsen, H B, Gerstoft, J, Larsen, C S, Pedersen, C, Pedersen, G, Obel, N & Benfield, T 2014, ' Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy : persistent high risk among HIV-infected injecting drug users ', Clinical Infectious Diseases, vol. 59, no. 8, pp. 1168-76 . https://doi.org/10.1093/cid/ciu558
BACKGROUND: Invasive pneumococcal disease (IPD) is an important cause of morbidity among individuals infected with human immunodeficiency virus (HIV). We described incidence and risk factors for IPD in HIV-infected and uninfected individuals.METHODS:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee36f2c9d2f5e857e0a52b0249c392c5
https://vbn.aau.dk/da/publications/3ae258a6-e97c-4bdd-98bf-e21cd519d06c
https://vbn.aau.dk/da/publications/3ae258a6-e97c-4bdd-98bf-e21cd519d06c